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1. Introduction
“Woe to the child kissed on the forehead who tastes salty, for it is cursed and soon must
die,” is a form of diagnosis for cystic fibrosis that dates back to the Middle Ages in Eastern
Europe [1]. This observation was rediscovered and made relevant in 1948 during a heat
wave in New York City. Paul di Sant’Agnese at Columbia University noticed that CF pa‐
tients had a larger incidence of heat prostration than others, due to excessive salt loss [2].
This ultimately led to the use of the “sweat test” (measurement of sweat electrolytes) as the
definitive test for diagnosing cystic fibrosis. Originally, Dorothy Andersen in 1938 created
the term cystic fibrosis [4] in describing the appearance of the pancreas from certain individ‐
uals. Later she went on to show that CF was a genetic disease [5].
Cystic fibrosis is the most common lethal genetic disease in the Caucasian population. As
first postulated by Paul Quinton it is now known that it is due to a lack of chloride flux, and
hence salt movement, in all affected organs [3]. For instance, in the coiled tube of the sweat
gland, fluid initially has roughly the same salt concentration as blood plasma (high Na+ and
Cl-). This fluid passes upward toward the skin surface through the sweat duct. Ions are re‐
absorbed into the body through the Na+ and Cl- (CFTR) channels. Thus salt is normally re‐
absorbed out of the sweat and the concentration falls to about 1/5 of blood plasma. But in
the disease cystic fibrosis the Cl- channels are either absent or non-functioning and the salt
concentration in the sweat remains high as it reaches the skin surface, which one can taste
on the forehand of a child with CF.
The gene itself was discovered through a remarkable collaboration by the lab of Francis Col‐
lins at the University of Michigan and those of Jack Riordan and Lap-Chee Tsui at the Uni‐
versity of Toronto in 1989 [6-8]. It was expressed and found to code for a small linear
chloride channel by Christine Bear and others [9].
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But the question remained, how did a missing chloride channel cause CF airway lung dis‐
ease? In many organs (pancreas, lungs, and reproductive organs) it was not understood how
the lack of salt movement led to the blockage of the pancreas, the disappearance of the vas
deferens and bacterial infection in the lung. But the link between genotype and phenotype
might have been more difficult to understand perhaps because we, the CF research field,
were initially focused too narrowly on just chloride.
It is easy to think only about sodium and chloride, as they are the main salt component of
plasma. But the second most common anion is bicarbonate. The CFTR channel is permeable
to bicarbonate [10] thus whenever it opens both chloride and bicarbonate can move through
it. With bicarbonate movement you can get corresponding changes in pH which have broad
effects. In CF, while the disease pathology in many organs is attributed primarily to im‐
paired Cl- conductance [11], manifestations in some organs have been difficult to attribute
solely to a defect in Cl- conductance [12]. Since CFTR is permeable to HCO3- and has also
been shown to regulate other membrane proteins [13,14] its absence in CF may lead to sig‐
nificant changes in intracellular or extracellular fluid composition in impacted organs. It is
the investigation into changes in pH and bicarbonate that are associated with the disease
cystic fibrosis, which we hope to summarize in this review.
2. Context #1: Organized by organ systems
During many years of research, scientists develop a mental encyclopedia for their field.
These expert mental databases often have the same knowledge flexibly organized in differ‐
ent manners. Much like a software database, an expert can re-conceptualize data in different
contexts. In the field of cystic fibrosis, an expert researcher tends to think about findings in
several context-dependent ways like: impacted organs, research groups, animal models and
chronology. We will organize several sections of this review in a similar format and then
conclude with a brief discussion of the latest findings.
It all began with the pancreas. The diagnosis and naming of the disease, cystic fibrosis, re‐
sulted when Dorothy Andersen saw a pattern of fibrotic cysts that formed on the pancreas
of a group of patients. That organ was first in the understanding of the disease and that or‐
gan was also first in detecting abnormalities related to pH. In the 1980s the in vivo patholo‐
gy that ravages the pancreas in cystic fibrosis was directly tied the CFTR malfunction
altering fluid and bicarbonate secretion in the pancreatic ducts [15,16]. Lost regulation of pH
is a problem caused by cystic fibrosis in that organ.
2.1. The pancreas
The pancreas is both an endocrine organ, releasing hormones such as insulin and glucagon
into the blood, and an exocrine organ, releasing digestive enzymes in a bicarbonate rich flu‐
id (pancreatic juice) into the intestines and eventually out of the body. Both of these systems
often become defective in individuals with cystic fibrosis. In healthy humans the pancreas
can produce 2 liters of concentrated sodium bicarbonate solution (140 mM) per day [17]. The
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exact mechanism for this remarkable feat is still controversial and certainly depends on the
exact species under investigation (the bicarbonate concentration in mice is only 70 mM).
Simply put, the model for a healthy functioning human pancreas requires an active apical
anion channel, that has some bicarbonate permeability, to be present in pancreatic duct cells,
which turns out to be CFTR. The other proteins involved are a basolaterally located sodium
bicarbonate cotransporter (NBC) needed to move bicarbonate into the duct cells and a Na-K
pump to maintain the sodium gradient and intracellular voltage. During secretion the intra‐
cellular chloride concentration becomes so low that chloride secretion cannot be maintained
and all the secretion is bicarbonate. This model was developed by many people [18] but was
put to an elegant test in a paper by Whitcomb & Ermentrout [19] where they mathematically
modeled the ductal secretion with predicted results that aligned exactly with those found by
organ studies. The controversy in this field is simply explained as whether another protein,
an apical chloride-bicarbonate exchanger, exists or is needed to produce the very high bicar‐
bonate concentrations detected. Muallem and others [20] have shown that there is an apical
membrane located chloride-bicarbonate exchanger found in mice. The activity of this ex‐
changer appears to be coupled somehow to CFTR. But it is not certain whether this same
system also is also normally active in the human pancreas.
On the other hand, the model for a poorly or non-functioning human pancreas impacted by
the disease cystic fibrosis involves chloride, bicarbonate and pH. When the critical apical
anion channel needed in duct cells, CFTR, is broken or missing, the system breaks down and
the pancreas cannot produce the alkaline solution it normally would. Likely the lack of
enough pancreatic juice to help dilute the enzymes secreted by the pancreatic acinar cells
leads to pancreatic insufficiency. There is also evidence from measurements in the duode‐
num that support the idea that liquid secreted from the CF pancreas has a much more acidic
pH [21]. The changed environment in the fluid secreted into the CF pancreatic duct leads the
pancreatic enzymes to form protein plugs and block the pancreatic ducts [17]. In addition
the secreted digestive enzymes, which are normally activated by acidic pH in the duode‐
num, may activate early and start to destroy the individual ducts. Eventually, with the help
of an abnormal immune response, enough ducts are destroyed or blocked that very few en‐
zymes reach the intestines to help digest fats and proteins, leading to the characteristic stea‐
torrhea seen in cystic fibrosis patients. Roughly 10% of CF individual are born without a
functioning pancreas. Over time this number climbs to 85% as more and more pancreatic
ducts are destroyed. Those 10-15% of CF patients with pancreatic sufficiency are associated
with mild CFTR mutations, or mutations that preserve some channel function.
It was work by Choi et al in 2001 [22] that brought the topic of the pancreas back to the fore‐
front of CF research. The amazing finding was that when they compared different mutations
of CFTR, they found that those channels with measureable residual bicarbonate conduc‐
tance were associated with the mild form of CF in pancreatic sufficient patients and the mu‐
tations of CFTR where bicarbonate secretion was lost were always associated with the more
severe version of CF, pancreatic insufficient. Later that year Jeff Wine [23] wrote a paper
bringing into question some of their findings. While there may be a correlation between bi‐
carbonate conductance and pancreatic sufficiency in cells in culture artificially expressing
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CFTR, in the sweat gland under normal conditions all the patients with pancreatic insuffi‐
ciency had high chloride concentration in their sweat gland secretions (the definitive test of
CF is the sweat chloride level as mentioned above) and those with pancreatic sufficiency
had intermediate sweat chloride levels, indicative of mild mutations that allowed for residu‐
al chloride conductance. While these sweat chloride measures supported that the chloride
conductance is important in the pancreas, bicarbonate has not since left the spotlight.
The destruction of the pancreas does not stop with just damaging the exocrine function but
eventually spreads to the endocrine pancreas. Cystic fibrosis related diabetes (CFRD) devel‐
ops when the ducts and cells responsible for delivering insulin to the blood supply are final‐
ly destroyed and the patient develops diabetes and needs insulin. CFRD is rare at birth and
develops over time. Patients with CFRD have a 6-fold higher mortality rate. It is unfortunate
that the loss of an anion channel in the pancreas can lead to such devastation. Fortunately
there is at least enzyme replacement therapy and insulin treatment for CF patients. This has
circumvented the mortality associated with the digestive system and failure-to-thrive so that
now 90% of all CF deaths are due to lung disease.
2.2. The lungs
In the 1940’s cystic fibrosis transitioned from a disease of the pancreas to a disease of the
airway. Many doctors were involved in clinical research at this time and it was Dr. Harry
Schwachman who tried to further the idea that what was known then as "cystic fibrosis of
the pancreas" was in fact a disease of many organs. At the same time Dr. Paul Di Sant’Ag‐
nese was using the newly discovered drug penicillin to treat lung infections associated with
cystic fibrosis. In the 1950’s Hans Ussing invented a method for investigating epithelium
named the Ussing chamber. The method helped standardize experiments on epithelia and
led to an increase in the scientific investigation of the organs affected in cystic fibrosis. It
wasn’t until the 1980s that the basic defect that leads to cystic fibrosis in the airways was
found.
Initially, Drs. Knowles, Gatsy and Boucher [24] measured the difference in voltage across
the nasal epithelium in 24 CF patients. They reported a much larger voltage in CF individu‐
als and this voltage could be greatly reduced by blocking the epithelial sodium channel with
amiloride. They speculated that excess sodium absorption could lead to excess salt and liq‐
uid absorption in the airway, leading to CF lung disease. Two years later they published an‐
other paper [25] “excessive active Na+ transport can account for the abnormalities” seen in
CF airway. And today excessive sodium absorption is still the leading hypothesis of how CF
lung disease develops.
To review what was mentioned earlier, in 1983 Paul Quinton published the seminal paper,
which correctly identified the CF defect as a loss of chloride permeability [3]. He focused his
studies on the sweat gland where any abnormality found could be attributed to the CF de‐
fect. It wasn’t until 1989 that Collins, Riordan and Tsui discovered the gene. They called it
the cystic fibrosis transmembrane conductance regulator (CFTR) because it was not yet cer‐
tain as to its function. In 1991 Bear and others expressed the CFTR gene and discovered a
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small linear anion channel as the gene product. It is with this background that bicarbonate
and pH became important in the airway.
One of the first reports of bicarbonate secretion in the airway was in the Ussing chamber. A
special method of studying epithelial cells as a monolayer in which only the electrical cur‐
rents moving into or out of the cells is measured. When cells are bathed in a solution that
lacks chloride the other major anion in airway fluid and blood plasma, bicarbonate, takes its
place. Smith and Welsh [26] reported that in airway epithelium under these special circum‐
stances an elevation of cyclic AMP (cAMP) in the cell opened a channel, which could carry
bicarbonate in normal tissue but was absent in CF tissue. The same thing happened when
the calcium inside the cells was increased except a different set of anion channels were
opened and bicarbonate can pass through in both normal and CF tissues. The following year
Smith and Welsh [27] published a paper studying electrolyte transport in cultured airway
epithelia cells. It was found that both normal and CF tissue secreted H+ in exchange for K+.
They discovered an apical hydrogen-potassium ATPase that works to absorb potassium
while secreting H+. It was noted that the H-K ATPase did not account for all the luminal
acidification and other mechanisms of H+ secretions may be present. In normal airway cells
the addition of forskolin to raise intracellular cAMP inhibited luminal acidification probably
by stimulating bicarbonate secretion through the activated CFTR channel. Poulsen [28] then
showed the same thing in transfected cells expressing the CFTR gene. C127 (mammary epi‐
thelia) and NIH-3T3 (fibroblasts) expressing normal wild-type CFTR could be made acidic
inside under certain conditions and the acidity was reduced only in healthy cells when for‐
skolin was added to the solution raising cAMP and opening CFTR channels. The alkaliniza‐
tion was not seen either in cells transfected with the mutant ∆F508 CFTR or non-transfected
cells that expressed no CFTR. They went on to measure the ratio of chloride to bicarbonate
permeability through the CFTR channel to be near 4:1 (3.9). Linsdell [10] then found the
same result of chloride to bicarbonate permeability of 4:1 (4.0) using single channel studies.
Hence 1 million bicarbonate ions could accompany the 4 million chloride ions that moved
through the CFTR channel every few seconds.
A second group later repeated the experiments on airway epithelium [29]. In a different culture
system both the apical culture liquid pH and the K+ concentration were measured. In unstimu‐
lated culture both the pH (or bicarbonate concentration) and the potassium concentration fell
over 24 hours. Activating CFTR resulted in alkalinization of the surface liquid in normal cul‐
tures while CF tissues were unaffected and just continued becoming more acidic. They also
went on to conclude the CFTR could conduct bicarbonate under normal conditions.
A seminal paper in 1992 was published that led a few of scientist to consider a different ori‐
gin of CF lung disease. The paper by Englehardt et al [30] showed by antibody staining of
CFTR channels was concentrated in the submucosal glands of the human bronchus. The
new paradigm was that since most of the CFTR was in the glands it was likely that CF lung
disease starts in the glands. Two scientists then led the investigation of airway submucosal
glands, Steve Ballard at the University of South Alabama studied intact glands in pig airway
and Jeffrey Wine at Stanford University initially studied a cell line model of gland cerous
cells (Calu-3) and later went on to study intact human glands. Lee et al in [31] and Devor et
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al in [32] had previously established the fact that Calu-3 cells secrete bicarbonate and we,
Krouse et al [33], went on to study acid and base secretion in Calu-3 cells. The cells secreted
base (bicarbonate) via CFTR and secreted acid via an H-K ATPase. We quickly became very
interested in the study of abnormal properties of the mucus secreted into the lungs from the
glands. In cystic fibrosis this demonstrated that even before newly made mucus reached to
the airway surface there was a mechanism to control the mucus pH that was altered dramat‐
ically in cystic fibrosis.
3. Context #2: Organized by research groups
Dorothy Andersen and her student Paul di Sant’Agnese at Columbia University led the first
CF research groups. To gain an understanding of the work done to date, we now present a
sample of the researchers in the United States who have helped make great strides in the
understanding of how bicarbonate movement and pH changes may influence the patho‐
physiology of cystic fibrosis.
3.1. Michael Welsh and Jeffrey Smith, University of Iowa, Iowa City, IA
Dr. Michael J. Welsh is one of the most productive scientists in the field of cystic fibrosis and
at the University of Iowa Medical Center has led one of the most respected CF research pro‐
grams in the US. His work with Dr. Jeffrey J. Smith has been significant for scientists inter‐
ested in examining pH abnormalities in CF. While the relevance of pH for the CF pancreas is
accepted and understood, the thought that pH might also be important in the pathology of
the human CF airway has only recently gained wide interest. The Welsh group takes ad‐
vantage of a variety of methods in their studies but cell culture studied by electrophysiolo‐
gy, and in particular use of the Ussing Chamber, is a common technique they apply.
As early as 1992, in the Journal of Clinical Investigation, Smith and Welsh [26] reported that
in studies with cultured canine and human epithelial cells cAMP stimulation of the CFTR
channel increases bicarbonate secretion across normal, but not cystic fibrosis, airway epithe‐
lia. In this paper they posed the question, might HCO3- may play role in CF? A year later
Welsh and Smith [27] reported their findings on how human epithelia cells control the quan‐
tity and composition of respiratory tract fluid. To do so they measured fluid and electrolyte
transport by cultured human nasal epithelia and found that elevated cAMP stimulated fluid
secretion across some epithelia, but for others the reverse, cAMP stimulated fluid absorp‐
tion. They also reported “The finding that cAMP agonists inhibited luminal acidification
may be explained by the recent finding that cAMP increases apical HCO3- conductance.”
These results provided new insights into how the intact airway epithelium may actively
modify the composition of the respiratory tract fluid which drew colleagues’ interest to the
very thin film of liquid lining the interior of the lung, the airway surface liquid (ASL).
In 1996 Michael Welsh and Jeffrey Smith [34] published a widely read paper in the journal
Cell where the reported a finding that cystic fibrosis airway epithelia fail to kill bacteria be‐
cause of abnormal airway surface fluid. Their evidence pointed to an abnormally high con‐
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centration of salt, NaCl, in the ASL that inhibits the killing of bacteria. This finding was
reminiscent of the high salt seen in CF sweat glands. This paper led to a very exciting time in
recent CF research. Numerous labs tried to measure the salt concentration in the lung. Some
found low salt in normal lung but most found the same salt concentration in the ASL of the
CF lung. The alternative hypothesis put forward, of how lung diseased develops, was the
model of Richard Boucher and others that the hyper absorption of the sodium leads to a de‐
pletion of the airway surface liquid, as mentioned earlier. Many people tried to find this de‐
pleted ASL in CF lungs but it has yet to found in vivo but does exist in cultures of airway
cells. In 2001 Smith and Welsh returned [35] to canine and human cells to test for the pres‐
ence of HCO3- transport in epithelial cells. They reported that their data suggest that cAMP
and Ca2+ stimulate HCO3- secretion across airway epithelium, and suggest that HCO3-
leaves the cell across the apical membrane via conductive pathways. They found the cAMP-
induced secretory response was absent in cystic fibrosis (CF) airway epithelial cells,
although Ca2+-stimulated secretion was intact. This result suggested that HCO3- exist at the
apical membrane is through the Cl- channel that is defectively regulated in CF epithelia.
These results also raise the possibility that a defect in HCO3- secretion may contribute to the
pathophysiology of CF pulmonary disease.
Most recently in 2012 [36] the Welsh group reported a dramatic finding, that their data sug‐
gests in the CF pig model that reduced airway surface liquid pH impairs bacterial killing in
the cystic fibrosis lung. It was found that the ASL pH is more acidic in pigs with cystic fibro‐
sis, so in the end increasing pH in ASL restored the bactericidal activity to the ASL from the
CF pigs. This finding will draw much attention in the years to come.
3.2. Robert Bridges, Rosalind Franklin University & University of Chicago, Chicago, IL
Robert Bridges joined the CF research group at the University of Alabama (UAB), Birming‐
ham in the mid 1980s. Dr. Krouse, an author, remembers meeting Dr. Bridges at a meeting
organized by the Cystic Fibrosis Foundation, where a number of researchers were discus‐
sing the purported rectifying anion channel as the CF channel. He was complaining pro‐
phetically that this small linear channel kept getting in the way of his single channel
recordings. In 1992 he teamed with Bear et al [9] to show that this small linear channel was
in fact the correct gene product of the CF gene (CFTR). Bob Bridges teamed with many dif‐
ferent CF scientists at UAB. With Neil Bradbury he help explore the role of CFTR in endo-
and exo- cystosis. In their Science paper from [37] they concluded, “CFTR is critical for
cAMP-dependent regulation of membrane recycling in epithelial tissues, and this function
of CFTR could explain in part the pleiotropic nature of cystic fibrosis.” Simply put, stimula‐
tion of CFTR not only opens the channel but causes insertion of CFTR containing vesicles
into the membrane and slowing removal of CFTR from the membrane. Thus increasing the
number of CFTR channels in the membrane.
In the mid 90’s Dr. Bridges moved to the University of Pittsburgh in Pennsylvania. There he
continued working on cystic fibrosis. His work with Dan Devor resulted in two papers in
1996 [38,39] that helped formulate the idea that chloride and bicarbonate secretion is de‐
pendent on the driving force for each anion. This work culminated in another paper in 1999
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[32] where they showed that Calu-3 cells secreted bicarbonate and this secretion is depend‐
ent upon the mode of stimulation. They ended their abstract with possibly the understate‐
ment of the year: “If these results with Calu-3 cells accurately reflect the transport properties
of native submucosal gland serous cells, then HCO3- secretion in the human airways war‐
rants greater attention.” In early 2000 Dr Bridges teamed with Martin Hug to investigate in‐
tact submucosal glands [40]. They found that the gland cells secrete bicarbonate in response
to stimulation. In order for cells to transport bicarbonate there must be a way for bicarbon‐
ate to enter the cells. In collaboration with Kriendler et al [41] they identified two sodium
bicarbonate cotransporters on the basolateral side of Calu-3 cells.
Dr Bridges’ other passion, like most CF scientists, is for finding a cure for cystic fibrosis. He
has collaborated with a variety of people testing various compounds for CFTR corrector ac‐
tivity. His papers are too numerous to mention here. After moving to Rosalind Franklin
University and Chicago Medical School he continued his interest in CFTR correctors. He is
head of the Cystic Fibrosis Foundation Therapeutics CFTR Modulator Chemical Compound
program. Each year he gives out compounds for others scientists to use and screens thou‐
sands of new possible compounds that may “cure” CF.
3.3. Shmuel Muallem, University of Texas Southwestern, Dallas, TX
Dr. Shmuel Muallem is the leader of a significant research group at the University of Texas
Southwestern and now at the NIH. One thread of his work relates bicarbonate transport to the
disease cystic fibrosis and has carefully examined and identified every potential element in the
mechanism of bicarbonate secretion by epithelial cells. He has done work using a variety of
methodologies centered on electrophysiology and patch clamp supported by molecular genet‐
ic approaches in his group’s studies to determine which genes are important for bicarbonate se‐
cretion. His research group also has published considerable research on other proteins which
are essential for bicarbonate secretion, focusing on bicarbonate-secreting exchanger proteins.
His work has greatly contributed to understanding the molecular mechanisms that explain cel‐
lular bicarbonate secretion and it’s role in the disease cystic fibrosis.
If we limit ourselves to this decade, Muallem’s first papers regarding the relationship be‐
tween bicarbonate transport and CF was published in 2001 [42]. It examined at the relation‐
ship between CFTR and a Na/H+ exchanger (NHE3) in pancreatic duct cells. His group
found evidence to support that CFTR indirectly regulated and inhibited Na/H+ exchange ac‐
tivity at the apical membrane via PDZ binding domains, which inhibited NHE3 activity. In
another study published in Nature [22] his research group found evidence that CFTR muta‐
tions associated with pancreatic insufficiency, the more severe version of cystic fibrosis, had
no HCO3- transport. And some of them still had good Cl- conductance. From a pH perspec‐
tive they found “alkaline fluids are secreted by normal tissues, whereas acidic fluids are se‐
creted by mutant CFTR-expressing tissues, indicating the importance of this activity.” This
Nature paper impacted the field in its suggestion that CF is not a result of Cl- transport
problems but rather it was all about CFTR’s conductance of bicarbonate ions. However, this
view did not exist long unchallenged as Jeff Wine published a paper establishing that the
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measurements of chloride conductance in these experiments did not agree with the data
from the sweat gland.
Muallem's group followed a significant paper in Nature with another in 2002 in the Journal
of Biological Chemistry [20], which presented evidence that CFTR, and NBC3 (sodium bicar‐
bonate cotransporter) are part of the same HCO3-transporting complex assembled with the
aid of PDZ domain-containing scaffolds, and this interaction is how CFTR regulates NBC3
activity. A few years later in 2006 [43] Muallem hypothesized that the Slc26a6 gene product
(a Cl/HCO3- exchanger) regulates and primarily inhibits CFTR activity. He followed that up
by adding that the SLC26 family of transporters may be part of a transporter complex with
CFTR where all regulate each other. The complex could be organized in PDZ domain scaf‐
folds (with NHE3 and NBC3) and each transporter protein has a specific role and all in the
apical membrane of epithelia. When taken altogether, the bicarbonate transport chain is
formed and in cystic fibrosis it does not function and leads to the disease state. Their model
supports that HCO3- secretion is vital to epithelia cells and is mediated by a cotransporter
pNBC1 at the basolateral membrane and exits the luminal side via the CFTR. Since 2009 his
group has published several papers identifying the mechanism by which this CFTR-NHE-
NBC complex is regulated by IRBIT and WNK/SPAK kinase pathways in the process of
HCO3- secretion.
3.4. Alan Verkman, University of California San Francisco, San Francisco, CA
Alan Verkman’s research group is a force of nature with an incredible variety of productivi‐
ty. Dr. Verkman’s research group works at the University of California San Francisco; and
his group uses microscopy and fluorescent dyes to enable the detection of ion concentra‐
tions, pH, and even precise measurements of the volume of the smallest intracellular com‐
partment. Their findings have greatly informed the field.
In the recent decade their work has focused on whether there are changes in Na, Cl, pH and
salts in general in the pathophysiology of cystic fibrosis. They often tested controversial
findings from researchers in the field and either supported or refuted their work. In the ear‐
ly years of this decade [44] they tested and refuted the “high salt” hypothesis of the Welsh
and Smith group. They found a similar ASL tonicity and pH in cystic fibrosis (CFTR-null)
mice as well as human bronchi. Their findings regarding Na and Cl levels being unchanged
led them to conclude this provided “direct evidence that the ASL is approximately isotonic
and not saltier in cystic fibrosis.” In 2001 they also published a report that measured the ion‐
ic composition and viscosity of fluid from airway submucosal glands. Neither Na+ nor pH
differed in gland fluid from CF airways versus controls but mucus viscosity was significant‐
ly elevated compared to normal airways [45]. In 2002 they reported that Cl- flux is important
to support the normal acidification process that occurs in the cell’s endosomes but CFTR
does not really change the acidification of endosomes because other Cl- channels, ClC-5, are
present, at least in mice [46]. This refuted a variety of hypotheses that endosome pH was
abnormal in cystic fibrosis, which perhaps altered the characteristics of mucus produced in
the airway.
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In a Journal of General Physiology paper in 2003 [47] they reported findings with a novel
lung preparation designed to measure ASL composition and depth in small distal airways.
Distal ASL was studied with ion- or pH-sensitive dyes. The ASL pH was found to be 7.28
and not affected when CFTR was inhibited by the drug CFTRinh-172.
In 2004 they started seeing pH differences. They tested airway submucosal gland fluid by
using a selective CFTR inhibitor (CFTRinh-172) in pig and human airways. Gland fluid pH
was 7.1 and was reduced by 0.4 units after CFTR inhibition [48].
In 2006 they investigated whether gland fluid pH is abnormal in early CF, using nasal biop‐
sies from pediatric subjects having minimal CF lung disease [49]. Having minimal disease is
very important as Fischer and Widdecombe published a paper showing the airway surface
pH changes with the longitudinal progression of different disease states. Gland fluid pH,
was 6.57 in biopsies from six CF subjects, much lower than the recorded pH of 7.18 in eight
non-CF biopsies. In pig trachea and human bronchi, gland fluid pH was also reduced by up
to 0.45 units by CFTR inhibitors. They found evidence for CFTR-dependent bicarbonate
transport by the tracheal epithelium and stated: “These results provide evidence for intrinsic
hyperacidity in CF gland fluid secretions, which may contribute to CF airway pathology.”
Their group’s recent papers have focused again on intracellular pH in the lysosomes of mac‐
rophages and epithelia from humans and mice and found no evidence it is altered in CF.
“We conclude that biologically significant involvement of CFTR in organellar acidification is
unlikely.” [50].
3.5. Paul Quinton and Malla Reddy, University of California, La Jolla, CA
In a publication in 1983 Paul Quinton [3] was the first investigator to make the connection
that cystic fibrosis might be caused by a broken Cl- channel. He also may have been the first
CF researcher to have the disease. When he was 19 he diagnosed himself, “I started reading
up on bronchitis and bronchiectasis out of curiosity about my own lung problems. When I
noticed a footnote that referenced cystic fibrosis, the definition of the disease gave me chills
because everything seemed to fit with what I was already experiencing.” Paul Quinton
works at the University of California-San Diego; his research with Dr. Malla Reddy has used
human cells and electrophysiological techniques to explore the problems in CF.
In the recent decade their work has focused on how changes in pH and bicarbonate ion con‐
centrations could lead in the pathophysiology of cystic fibrosis through changes in mucus.
In the year 2000 Quinton and Reddy [51] reported that they found the CFTR anion channel
is somewhat permeable to bicarbonate anions. At the time Quinton was unsure that this
new fact was relevant to the pathogenesis of cystic fibrosis at normal physiological levels. In
a 2001 paper in the Journal of the Pancreas [52], Quinton and Reddy found evidence that the
presence of mutated CFTR correlated to a decrease in cell membrane permeability to bicar‐
bonate ions. They also found that the severity of disease was related to the phenotypic abili‐
ty of a mutant CFTR to express a bicarbonate conductance and different CF mutations may
have differing level of bicarbonate conductance, this is very similar to the views expressed
by Shmuel Muallem about the loss of bicarbonate conductance being the most important
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this in the pancreas. They surmised that the severity of the pathogenesis in CF might be
closely related to the phenotypic ability of a mutant CFTR to express a HCO3- conductance.
Very recently, in 2010, Paul Quinton reported in the Journal of Physiology [53] that CF epi‐
thelial cells in the cervix could secrete fluid normally, but unlike wild type cells, they could
not secrete bicarbonate. And furthermore that mucus released in CF epithelial was severely
impaired even though stimulated fluid secretion was similar to healthy cells. They reported
“Mucus release was severely inhibited in the absence of serosal HCO3-, HCO3- transport, or
functional CFTR.” In the same year in an American Journal of Physiology report the [54]
Quinton group found that extracellular bicarbonate is necessary for mucoviscosity. They hy‐
pothesized that extracellular bicarbonate could chelate calcium from the mucins at the mo‐
ment of secretion to allow the mucins to fully expand. In CF disease the mucins don’t fully
expand and appear as “dehydrated mucus.” Lastly in a 2010 review, Quinton [55] put for‐
ward the possibility that mucus build up in cystic fibrosis patients may largely be caused by
bicarbonate disruption, not by salt/fluid imbalance as traditionally explained. This now has
supplemented an existing hypothesis of how lung disease develops, that is that the mucus
from the submucosal glands is already defective as it emerges and adheres to the glands and
airway surface providing an island for bacterial growth. In this case though, Paul Quinton
has put forward a mechanism (mentioned above) whereby lack of bicarbonate leads to this
sticky mucus. This will lead to many more experiments as it is tested.
3.6. Steve Ballard, University of South Alabama, Mobile, AL
Steve Ballard started his career in cystic fibrosis research working with Richard Boucher and
John Gatzy at the University of North Carolina at Chapel Hill. His first paper [56 helped
form the basis for one of the leading model of CF lung disease. That is that alveolar cells
secrete fluid and the rest of the lung absorbs that fluid. After moving to the University of
South Alabama in Mobile, Ballard and others [57] showed in distal bronchi that most of the
secretion comes from submucosal glands. This helped form the basis for a second model of
CF lung disease. That is that the disease pathophysiology of cystic fibrosis originates in the
submucosal glands. In subsequent papers [58,59] the Ballard lab showed that bronchial se‐
cretion was due to both chloride secretion and bicarbonate secretion.
In 1997 Steve Ballard and others [60] published a paper on the visualization of bronchial
submucosal glands from pigs. Dr. Krouse, an author, remembers watching their movies of
submucosal glands secretion, with the gland orifice opening, mucus streaming out and cilia
beating, showing that glands were an exciting dynamic part of airway fluid secretion. In the
same year they discovered that “inhibition of the anion (chloride and bicarbonate) secretion
response to acetylcholine leads to mucus obstruction of submucosal gland ducts that resem‐
bles the early pathological changes observed in CF.” This result provided another link be‐
tween cystic fibrosis and submucosal gland function. In the following paper [61] they also
noted that the mucus (after inhibition of anion secretion) on the airway surface was differ‐
ent, having less water and altered rheology, similar to CF.
By the turn of the century the Ballard lab had established that most of the secretion in the
upper airway was due to chloride and bicarbonate secretion through CFTR in the submu‐
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cosal glands. That inhibition of anion secretion leads to impacted mucus within glands and
defective mucus on the airway surface. In a paper by Trout et al. [62] they showed that
much more of the airway is covered by defective mucus when the glands are stimulated to
secrete and there was no measureable goblet cell secretion. They concluded that the source
of the defective mucus on the airway surface was from the submucosal glands. They con‐
cluded, “that inhibition of anion and liquid secretion in porcine lungs disrupts the normal
morphology of airway surface mucus, providing further evidence that impaired anion secre‐
tion alone could account for critical aspects of CF lung disease.” In 2004 Ballard and Inglis
[63] published an excellent review summarizing their findings.
3.7. Terry Machen and Horst Fischer, University of California Berkeley, Berkeley CA
Drs. Terry Machen and Horst Fischer have been collaborators at the University of California
Berkeley for two decades and were perhaps the first group to put forward the idea that pH
and HCO3- may be aberrant in the disease cystic fibrosis. They most frequently use the
methods of electrophysiology, including transepithelial short-circuit current measurements
by Ussing Chamber (sometimes with pH-stat technique), whole cell and single cell patch
clamp techniques, and nasal potential difference (PD) measurements from living subjects.
An early PNAS paper [28] directed the field's attention to the topic HCO3- permeability
through the CFTR channel. Their study assessed intracellular pH and channel activity of
mouse wild type or mutant CFTR-expressing epithelial cells. They found evidence that
HCO3- could move into cells through CFTR channels and hypothesized since the electro‐
chemical gradients of both Cl- and HCO3- are physiologically directed outward, "HCO3- se‐
cretion may be important for controlling pH of the luminal, but probably not the
cytoplasmic, fluid in CFTR-containing epithelia. In CF, a decreased secretion of HCO3- may
lead to decreased pH of the luminal fluid."
In a 1996 Pflugers Archives paper [64] this research group studied intracellular pH regula‐
tion using a florescent dye, BCECF, and cultured bovine epithelial cells. They again found
evidence that HCO3-dependent, Na and Cl- independent, pHi recovery may be due largely
to an influx of HCO3- via CFTR Cl- channels. They suggested that CFTR may mediate
HCO3- secretion and contribute to regulation of pH in periciliary fluid. In the following
American Journal of Physiology paper [65] they extended this line of inquiry in Ussing
Chambers and using a variety of channel blockers. The found "Blocker effects were absent in
human CF tracheal cells homozygous for the delta F508 mutation of CFTR (CFT1); Cl- and
HCO3- currents were rescued in CFT1 cells recombinantly expressing wild-type CFTR. Thus
CFTR functions as a HCO3- and Cl- conductor, and genistein and bromotetramisole maxi‐
mize CFTR activity in airway epithelial cells." In 1999 in Pflugers Archives [66] they evaluat‐
ed a new cell model for airway submucosal gland cells, Calu-3, and reported data
elucidating the ion selectivity of the CFTR channel.
Their research group also explored another question related to pH, whether the intracellular
organelles like the endosome, lysosome or golgi which acidify themselves are altered in
cystic fibrosis. In a Chandy et al [67] paper they used pH-sensitive dyes targeted to the golgi
apparatus and reported "Comparison of genetically matched DeltaF508 and wt-CFTR cells
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showed that the absence of CFTR statistically increased Golgi acidity by 0.2 pH units,
though this small difference was unlikely to be physiologically important." In 2006 Fischer
co-authored a review paper with Jonathan Widdicombe [68] which directed the fields atten‐
tion to mechanisms that might explain pH changes in the lung's airway surface liquid, ASL,
could alter the function of antimicrobial factors that mean to keep the lung sterile. They also
point out: "CFTR Cl- channel conducts HCO3- and, therefore, may contribute to ASL pH.
However, the acidity of the ASL indicated parallel mechanisms for H+ secretion. Recent in‐
vestigations identified several H(+) transporters in the apical membrane of the airway epi‐
thelium." Thus we should not ignore the role proton channels will also play in modifying
pH in the airway surface liquid. In a recent publication [69] this research group explored hu‐
man nasal mucosa pH and rate of acid and base secretion using Ussing chambers and the
pH-stat technique. They found the pH of nasal epithelia from CF patients was pH = 7.08
while that in normal subjects was pH = 7.34. They conclude with "Our data suggests that CF
patients exhibited significantly lower base secretion by the nasal airway epithelium. It is
possible that improper regulation of ASL pH in CF may negatively impact the innate host
defense system."
3.8. Lane Clarke, University of Missouri, Columbia, MO
Lane Clarke started studying cystic fibrosis at the University of North Carolina, Chapel Hill,
under the guidance of Richard Boucher and Mike Knowles. Their first paper together [70]
showed that cystic fibrosis patients responded to extracellular ATP and UTP, suggesting the
presence of functional P2 receptors in the airway. In 1992 Clarke et al [71] showed that in the
newly engineered CF mice that there was a lack of chloride transport in the mouse intestine.
In 1993 they [72] explained one of many CF mysteries. They found evidence that the channel
originally claimed to be the CF channel (the outwardly rectifying anion channel) was regu‐
lated by CFTR. This could explain the earlier findings that the rectifying channel was not
gated properly by cAMP in CF tissues.
Upon moving to the University of Missouri, Lane Clarke continued his work on epithelia,
especially the intestine. With Harline in [73] he published a paper that CFTR was responsi‐
ble for both chloride and bicarbonate secretion in the mouse duodenum. He also found an
chloride/bicarbonate exchanger in the intestine that was regulated by CFTR. He also descri‐
bed an apical H-K ATPase in the mouse colon [74]. It is interesting in two systems, the lungs
and the intestine, there exists a mechanism for secreting both base (bicarbonate) and acid (H
+). Two years later the Clarke group found yet another mechanism by which CFTR controls
the apical pH [75], they found evidence that CFTR regulates a Na+/H+ exchanger.
In 2004 Dr. Clarke published a paper [76] that changed the thinking on how CF disease de‐
velops and added a new word, bioavailable, to our vocabulary. They showed that “Paneth
cell granules undergo limited dissolution and accumulate within the intestinal crypts of
cystic fibrosis (CF) mice.” These granules should carry the antimicrobials from the Paneth
cells to the intestinal surface. In CF the antimicrobials are secreted into the crypts but are not
bioavailable to help kill bacteria. This result influenced people like Jeff Wine where it was
hypothesized that the antimicrobials secreted by the airway submucosal glands are not bioa‐
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vailable on the airway surface where they are needed. In 2009 [77] the Clarke lab identified
the anion exchanger that is regulated by CFTR. It was named "Down-regulated in adenoma"
(DRA later changed to be SLC26A3) and was responsible for all the basal bicarbonate secre‐
tion and ½ of the cAMP stimulated current in the mouse intestine.
Lane Clarke has shown that in the intestine, the CFTR is a member of a large family of pro‐
teins that can regulate the pH within the organ. Describing the huge variety of bicarbonate
secretors and acid secretors involved in intestinal pH regulation the Clarke's research group
unearthed would take a review of its own and will not be attempted here.
3.9. Mike Knowles and Richard Boucher, University of North Carolina, Chapel Hill, NC
Mike Knowles and Ric Boucher first teamed up at the University of North Carolina, Chapel
Hill in 1981 [78,79] and adapted technique of measuring the difference in voltage across the
nasal epithelium to humans. They quickly applied this new technique to cystic fibrosis
where the potential difference in CF was much higher than in normal individuals. Much of
the potential difference could be inhibited by amiloride, which blocked the apical sodium
channel (ENaC). This led them to conclude, “the greater reduction in potential difference in
response to amiloride suggests that absorption of excess salt and perhaps liquid from respi‐
ratory epithelial surfaces contributes to the pathogenesis of lung disease in cystic fibrosis.”
This was the basis for the leading theory of how CF lung disease develops. The airway ab‐
sorbs too much liquid via increased sodium absorption leading to dehydration of the mu‐
cus. The dehydrated mucus becomes plastered to the airway surface and provides a
breeding ground for bacteria. This was the theory in the 1980’s and is still the theory today,
with minor modifications. In another paper [80] they agreed with Paul Quinton that there is
loss of chloride permeability in CF, but the cause of CF lungs disease was still the excess flu‐
id absorption. The link between the loss of an anion channel and the activation of a sodium
channel was not clear at that point and many researches in the field searched for the link.
In collaboration with Jim Yankaskas [81] they discovered that CF epithelial cells retained the
characteristic chloride permeability loss and sodium absorption increase in culture. In 1986
they published a review [82] which is a good summary of the early history of CF. To test the
theory that excess sodium absorption was the problem, they did a pilot study [83] of the ef‐
fect of amiloride on 14 CF patients over 1 year. The loss of forced vital capacity over that
year was slowed and the rheology of the sputum improved. Thus it appeared that blocking
ENaC might provide a way to help cure or prevent CF lung disease.
In the mid 90’s, thanks to a paper published by Smith et al [34], there was a big debate
whether the salt concentration in the surface liquid was different between normal and CF
cells. Simply put, was the airway like the sweat gland and CF individuals had salty airway
fluid? In 1997 Knowles and Boucher [84] published a paper where they measured the ion
concentrations. They used filter paper to sample the airway liquid and found no difference
in any concentration between normal and CF. Interestingly, they found very little anion gap
(supposedly bicarbonate) in CF or normal airways. The only thing odd was the very high
concentration of potassium in the fluid (between 15-30 mM).
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In 2002 Knowles and Boucher [85] published an excellent review of their view on how CF
lung disease develops. The work included many scientists at their institution and other pla‐
ces, too many to cover here. In their model a healthy lung's alveoli secrete large amounts of
fluid that the rest of the lung absorbs via sodium absorption. Yet in CF the increased ENaC
activity in the airway leads to a dehydration of the airway surface until the fluid level drops
below that of the height of the cilia. The mucus becomes dehydrated and stationary, a stable
island more easily colonized by bacteria. This does not happen across the entire lung in gen‐
eral as the act of breathing and walking releases ATP onto the surface in many places and
opens a second chloride channel, which supports rehydration. However the hydration bal‐
ance of the CF airway is very precarious. Insults to the airway such as noxious fumes or vi‐
ruses upset the balance and lead to a patchy distribution of bacterial infection in the lung.
3.10. Jeffrey Wine and Mauri Krouse, Stanford University, Stanford, CA
Dr. Jeffrey Wine switched the whole direction of his research in 1986. Turning from a suc‐
cessful career in crayfish behavior to trying to find the cause and cure for cystic fibrosis. Jeff
came to Stanford in the early 1970's as an assistant professor of psychology. In 1981, doctors
diagnosed his first daughter Nina with CF, forever changing his personal and professional
life. "My daughter could have been born with many diseases and I wouldn't have decided to
work on them. But I saw a paper that said CF is an ion channel disease and I knew about ion
channels," Wine recalled. Moving from the science of neurons to the function of CFTR in ion
channels marked a change in focus that led to 30+ years of contributions to understanding
the basic defect in CF. After a sabbatical in Paul Quinton's research lab, just one year, he
published his first paper with Behm et al [86] expanding on the previous work of Sato and
Quinton. His paper is still important today as it measured the secretion rate in sweat glands
and found that CF heterozygotes had ½ the secretion rate of normals whereas CF sweat
glands have no secretion to beta-adenergic stimulation.
Some 24 of those years he worked in collaboration with Dr. Mauri Krouse. I joined the Wine
lab at the very beginning of its transition to CF work, in 1986, which also was the year when
two papers (see section on Mike Welsh) were published claiming to have discovered the
chloride channel (an outwardly rectify chloride channel) that was defective in cystic fibrosis.
The laboratory of Prof. Wine could not repeat these experiments and found it likely CF was
caused by another channel. Jeff Wine led a 5-year campaign to discover the correct anion
channel that was the cause of cystic fibrosis. In a meeting of the North American Cystic Fib‐
rosis society in 1990 in Arlington Virginia, Wine and Krouse, with collaborators from Stan‐
ford University, submitted an abstract on a small linear chloride channel that was activated
by cAMP in canine airway cells. This was followed up with a paper the next year [87] where
they showed the small linear anion channel and finding no correlation between the claimed
outwardly rectifying chloride channel and levels of CFTR expression. Others at that 1990
meeting had also noted the small linear chloride channel such a M.A. Gray and B. E. Argent
from the UK and Dr. Grygorczyk from Canada. In 1991 the CFTR channel was confirmed as
a small linear chloride channel by Bear et al when they expressed recombinant CFTR in cells
[9]. Once the small CFTR channels identity was confirmed Wine and Krouse teamed with
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Christine Haws to be the first to describe a kinetic model for the gating of CFTR [88]. This
model has since been modified and expanded, by researchers such as David Sheppard in the
UK and TC Hwang in Missouri, but it was the first. This same year a very influential paper
from Engelhard et al [30] was published using “in situ hybridization and immunocytochem‐
istry to characterize the cellular distribution of cystic fibrosis (CF) gene expression in human
bronchus.” They discovered that most of the CFTR in the lung was in the submucosal
glands. After reading this paper Jeffrey Wine again changed the course of his lab to almost
exclusively study submucosal glands. Within two years he helped discover the now famous
submucosal gland cell line (Calu-3) with the labs of Drs. Walt Finkbeiner and Jonathan Wid‐
dicombe at UCSF [89]. Again Christine Haws worked to carefully measure the channel
properties of CFTR in Calu-3 cells.
Unfortunately the Calu-3 cells represented healthy tissue and there was no CF version of the
cell (even though many people have tried the make some), thus Haws, Krouse and Wine
[90] used a stably transfected mouse mammary cell line to measure the properties of ΔF508
CFTR. The values they found over 16 years ago are still true today. The channel density of
ΔF508 CFTR on the surface is less than 5% of wild type and the open probability is ~ 1/3 of
normal CFTR. With the realization that the main form of cystic fibrosis was due to the loss
of channels, Prof Wine abandoned patch clamping single cells and concentrated on sheets of
cells in the Ussing chamber. Monolayers of Calu-3 cells secreted bicarbonate [31] and most
of the unstimulated resting secretion was bicarbonate-dependent [91]. Work with Luckie et
al (92) found evidence that in a variety of cells expressing CFTR that bicarbonate may be se‐
creted because mutant non functional CFTR altered the pH surrounding cells.
Using and ingenious method Irokawa [93], and Wine designed a chamber where all the se‐
cretion of a sheet of epithelial cells was secreted out a tiny orifice, they called the apparatus
the “virtual gland.” When Calu-3 cells were tested in the virtual gland the bicarbonate con‐
centration of the fluid secreted to carbachol (a Ca2+ elevating agonist) was the same as the
bathing solution (25 mM), but when the cells were stimulated with forskolin (a cAMP ele‐
vating agent the opens CFTR) the bicarbonate concentration rose to ~80 mM. Roughly half
the secretion was due to bicarbonate secretion in the virtual gland. This was confirmed by
Krouse et al [33] in the Ussing chamber with the addition that there existed a H-K ATPase to
help neutralize some of the bicarbonate which was secreted. Such a mechanism had been
previously reported by Smith and Welsh [27] in airway cells and again by Coakley et al [29]
in primary airway cell cultures. In the same year Wu et al [94] published a paper showing an
inwardly rectifying potassium channel (Kir4.2) in the apical membrane of Calu-3 cells and
also in the apical membrane of freshly dissected airway submucosal glands. This channel
may supply the potassium needed by the H-K ATPase.
In recent years the Wine research group has been in the middle of the most exciting topics in
the field, new studies on mucus [95], new drugs developed to correct the disease [96] and
the hottest topic in the research field today, the CF Pig [97,98].
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4. Final context: What's new, what's next?
Everything new these days in the field of cystic fibrosis research seems to have something to
do with a pig. The birth announcement for the first CF pig occurred in 2008 [99]. It was a
collaboration of over 20 people at the University of Iowa and the University of Missouri.
They noted that “these pigs should be of value in producing new models of CF” and they
certainly have. While CF mice do not develop lung disease, CF pigs do. The pathology of the
newborn pig mirrors that of human infants [100]. They have involvement of the pancreas,
intestines (including meconium ileus), liver and gallbladder. In the pig lungs have no initial
inflammation or infection. Within months the CF piglets develop infection, inflammation,
remodeling and mucus accumulation [101] just like human lungs. The piglets failed to clear/
eradicate bacteria in the lungs suggesting a defective defense system that was apparent
within hours after birth. An unexpected finding was reduced levels of insulin-like growth
factor were reduced in the CF pig [102]. When human CF infants were tested they found a
reduced IGF1 level. This finding might explain why some patients fail to reach their full
growth potential even under the best clinical care. It also suggests a new IGF1 supplement
therapy for newborns with CF.
A closer look at the lung of CF piglets revealed that there was a loss of both chloride and
bicarbonate secretion [103]. They found no increase of sodium or liquid absorption and no
change in the depth of the periciliary liquid depth. The defect in sodium transport is the
hallmark of the leading hypothesis of how airway lung disease develops. But the authors
point out that these neither are not mature pigs nor are they ∆F508 pigs, but rather piglets
lacking CFTR. In 2011 a study of ∆F508 pigs was published [104], even though about 6%
(compared to normal) CFTR makes it to the cell surface the results are the piglets are almost
identical with the earlier knockout experiments. The lungs still display a greatly reduced
chloride and bicarbonate secretion. A second unexpected finding was that the teeth of CF
piglets are hypomineralized [105]. Both CFTR and an anion exchanger (AE2) expression
went up during the enamel maturation stage. They proposed that there is an increased de‐
mand for chloride and/or bicarbonate during the development of the teeth.
Just this year the CF pig revealed another important clue to the pathogenesis of CF airway
disease. At birth CF lungs are sterile and the infection is due to a defect in a basic defense
mechanism so that the bacteria are not eradicated. In a recent Nature paper [36] they found
that the pH of the airway surface liquid determines the killing properties of the lungs. Air‐
way surface liquid from normal piglets effectively killed bacteria and if the pH was made
more acidic the killing was reduced. The airway surface liquid from CF pigs did not kill bac‐
teria until the pH was made more alkaline. To quote from their abstract “these results direct‐
ly link the initial host defense defect to the loss of CFTR, an anion channel that facilitates
HCO3- transport.” This paper just might be a new paradigm shift for how a loss of an anion
channel leads to CF lung infection.
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5. Conclusions
The future is bright for the CF pig. And perhaps the most dramatic finding for those who
study pH is the one by Pezzulo et al [36]. They found evidence in CF pig model that reduced
airway surface liquid pH impairs bacterial killing in the cystic fibrosis lung. This stands
upon an earlier finding by Verkman's group when they found that gland fluid pH is abnor‐
mal in early CF, using nasal biopsies from pediatric subjects having minimal CF lung dis‐
ease before bacteria and immune response could disturb the system [49]. Thus the reduced
pH in the thin layer of fluid that lines the lungs may play an important role in the ability of
pathogenic bacteria to colonize the airway in cystic fibrosis.
Beyond the alteration of pH, bicarbonate itself may play an important role in the abnormal
behavior of mucus in cystic fibrosis. Quinton's new hypothesis [55], that in a healthy person
the extracellular bicarbonate functions to chelate calcium from the mucins at the moment of
secretion to allow the mucins to fully expand but in CF the mucins don’t fully expand and
appear as “dehydrated.” The possibility that mucus build up in cystic fibrosis patients may
largely be caused by bicarbonate disruption, not by salt and fluid imbalance, is intriguing
idea from a man who has been correct before.
These results discussed in this review provide evidence for an intrinsic defect in the ability
of CF tissues to secrete base [29] or regulate pH, and they come closer to conclusively dem‐
onstrating that CF airway surface liquid is abnormally acidic. More data needs to be collect‐
ed concerning the steady-state pH of the airway surface liquid of humans under
physiological conditions. If such a pH difference is eventually established, it will then be
necessary to determine if attempts to correct it might improve the health of patients.
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